Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 249 participants.

Also called NCT02586129

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 249 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02586129
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02586129. Randomized; double masking; primary purpose treatment. Start 2015-11-04 (actual); primary completion 2017-07-07 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes
Condition
Dyslipidemia
Condition
Type II Diabetes
Intervention (Drug)
YH14755
Intervention (Drug)
Metformin
Intervention (Drug)
Rosuvastatin
Lead sponsor
Yuhan Corporation (class: industry)

Record details

Record id
cardio:ct-nct02586129
Content hash
671380d4b370a0c9ac108c094b93e1909816b33be0b189d65c2fc948a7534893